Abtrace

Automated Call / Recall – Delivering population scale proactive monitoring, prioritisation and clinical productivity in primary care

Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases

Patients with chronic disease, who account for 90% of healthcare costs, require regular and proactive monitoring to ensure safe primary and secondary prevention. Abtrace has developed and clinically validated an NHS Digital approved, UKCA marked, fully integrated intelligent automation software platform which has been rolled out in practices across England. The platform eliminates unnecessary duplication of workload and improves coverage of the care patients should receive in disease prevention, particularly for Cardiovascular Disease – making sure more people get the right care whilst reducing workload and proactively targeting health inequalities.

Within one year of implementing Abtrace, an ICS covering 1.2m patients would potentially improve 57,000 high risk patients’ blood pressure control by automating patient monitoring and management. A further 120,000 patients with undiagnosed hypertension could be identified and this translated into savings in excess of £45 million.

An automated recall feature has been launched which instantly identifies and contacts patients who are due monitoring, inviting them to use a self-booking link to arrange a relevant appointment. At one practice, 80% of patients due blood pressure monitoring had an updated reading in just four weeks after enabling the automated recall feature. This has freed up time for practices by eliminating the need for manual recall processes and allowed them to redirect their focus to direct clinical care.

The tool also includes real-time population-level recall dashboards, allowing users to instantly evaluate the monitoring status for each patient in a single view. Automatically prioritising the patients most in need, enables clinicians to direct their time to underserved patients and tackle inequalities at population-scale. Wider-scale analytics dashboards enable practices to track their performance against key cardiovascular disease-related targets, enabling teams to manage and plan their workforce capacity.

Dr Umar Naeem Ahmad, CEO

• Live across 250+ practices in 30 ICBs, and Abtrace's searches monitor over 3m patients every day
• Ranked as one of the World’s Best Digital Health Companies (2024) by Newsweek and Statista R, and recognised as the Company with Significant Growth (2024) by the Digital Health London Accelerator
• Estimated savings of 160t of CO2 emissions per year through streamlining the monitoring and recall process; resulting in savings in clinical equipment and reduced duplication of appointments
• UKCA CE Mark and NHS Digital approved
• Supported by UCLPartners, Innovate UK, UKRI, NIHR, EIT Health, and the Digital Health London Accelerator
• ISO27001, GDPR, NHS DS&P toolkit, Cyber Essentials Plus, DTAC certified

“Staff are raving about Abtrace, just a fantastic addition. Our HCAs and pharmacists are making a huge difference to patient care with it. It really is a massive game changer due to the visual presentation, data recording and also the population tool for our LTC manager."

GP Partner

December 2024